Oncolytic herpes simplex virus infects myeloma cells in vitro and in vivo

Because most patients with multiple myeloma (MM) develop resistance to current regimens, novel approaches are needed. Genetically modified, replication-competent oncolytic viruses exhibit high tropism for tumor cells regardless of cancer stage and prior treatment. Receptors of oncolytic herpes simpl...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Mol Ther Oncolytics
Huvudupphovsmän: Ghose, Jayeeta, Dona, Ada, Murtadha, Mariam, Gunes, Emine Gulsen, Caserta, Enrico, Yoo, Ji Young, Russell, Luke, Jaime-Ramirez, Alena Cristina, Barwick, Benjamin G., Gupta, Vikas A., Sanchez, James F., Sborov, Douglas W., Rosen, Steven T., Krishnan, Amrita, Boise, Lawrence H., Kaur, Balveen, Hofmeister, Craig C., Pichiorri, Flavia
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society of Gene & Cell Therapy 2021
Ämnen:
Original Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7940704/
https://ncbi.nlm.nih.gov/pubmed/33738338
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omto.2021.02.009
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk